[
  {
    "ts": null,
    "headline": "Pfizer's Golden Cross Signals Strength: How to Play the Stock",
    "summary": "Pfizer trades above key SMAs with a golden cross, while new drugs and cost cuts drive growth despite looming headwinds.",
    "url": "https://finnhub.io/api/news?id=766b7bbe3cfaf3f14842b487bb761254e5a7e1e7add1dbf89f118fba2d7c5ac2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756745940,
      "headline": "Pfizer's Golden Cross Signals Strength: How to Play the Stock",
      "id": 136604057,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer trades above key SMAs with a golden cross, while new drugs and cost cuts drive growth despite looming headwinds.",
      "url": "https://finnhub.io/api/news?id=766b7bbe3cfaf3f14842b487bb761254e5a7e1e7add1dbf89f118fba2d7c5ac2"
    }
  },
  {
    "ts": null,
    "headline": "A Look at Pfizer’s Valuation After FDA Approval of Next-Gen COVID Vaccine for Older Adults and High-Risk Groups",
    "summary": "If you have been watching Pfizer (PFE), the latest FDA approval is hard to ignore. On August 27, the U.S. Food and Drug Administration gave the green light to Pfizer and BioNTech’s updated COVID-19 vaccine for older adults and high-risk individuals. This move could breathe new life into Pfizer’s vaccine revenues. It is the kind of regulatory event investors tune in for, especially after a period where vaccine demand seemed to be winding down. This comes as Pfizer’s share price has seen a...",
    "url": "https://finnhub.io/api/news?id=479e539b22e273eb512fc3916943e0e270a10831bc1b0ebf9c21066e7fee290c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756724780,
      "headline": "A Look at Pfizer’s Valuation After FDA Approval of Next-Gen COVID Vaccine for Older Adults and High-Risk Groups",
      "id": 136596298,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "If you have been watching Pfizer (PFE), the latest FDA approval is hard to ignore. On August 27, the U.S. Food and Drug Administration gave the green light to Pfizer and BioNTech’s updated COVID-19 vaccine for older adults and high-risk individuals. This move could breathe new life into Pfizer’s vaccine revenues. It is the kind of regulatory event investors tune in for, especially after a period where vaccine demand seemed to be winding down. This comes as Pfizer’s share price has seen a...",
      "url": "https://finnhub.io/api/news?id=479e539b22e273eb512fc3916943e0e270a10831bc1b0ebf9c21066e7fee290c"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer's 7% Dividend: Income Gem or Value Trap?",
    "summary": "The pharmaceutical giant currently offers a 7% yield, but dividend investors need to look beyond the headline number.",
    "url": "https://finnhub.io/api/news?id=d6c45500a002fb7fd4832767e4472e4b675022f5d9796420aef2dd4ae5f12b0f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756724400,
      "headline": "Pfizer's 7% Dividend: Income Gem or Value Trap?",
      "id": 136596299,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The pharmaceutical giant currently offers a 7% yield, but dividend investors need to look beyond the headline number.",
      "url": "https://finnhub.io/api/news?id=d6c45500a002fb7fd4832767e4472e4b675022f5d9796420aef2dd4ae5f12b0f"
    }
  },
  {
    "ts": null,
    "headline": "Dividend Income: Lanny's June 2025 Summary",
    "summary": "In June, we (my wife and I) received a dividend income total of $5,403.93. We had a booming 4 dividend increases this month",
    "url": "https://finnhub.io/api/news?id=1c046a7258d786c22490242969b058f09f7c9de604f2e29101add172cb380fa5",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756703760,
      "headline": "Dividend Income: Lanny's June 2025 Summary",
      "id": 136594963,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1310163825/image_1310163825.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "In June, we (my wife and I) received a dividend income total of $5,403.93. We had a booming 4 dividend increases this month",
      "url": "https://finnhub.io/api/news?id=1c046a7258d786c22490242969b058f09f7c9de604f2e29101add172cb380fa5"
    }
  }
]